Connect Sign In
Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of more than 150 peer-reviewed articles.
Two years into the COVID-19 pandemic, when the highly contagious Omicron variant of SARS-CoV-2 has infected millions in the United States alone, most of us have some immunity against the virus.
ARUP Transfusion Medicine has partnered with machine-learning experts at the U of U to develop and validate a method that can predict the need for transfusion during cardiothoracic surgery.
PacBio and ARUP Laboratories announced they are collaborating on a study intended to evaluate whether the solve rate for rare disease cases can be increased.
A new antibody test that has earned EUA from the FDA effectively detects SARS-CoV-2 neutralizing antibodies, according to an analysis recently published by experts at ARUP Laboratories.
ARUP’s Adam Barker, PhD, will be the featured presenter during the Dark Intelligence Group’s COVID-19 STAT Intelligence Briefing at 10 a.m. MDT on Tuesday, April 27.
The CDC has cited research in which the University of Utah’s HERO Project and ARUP Laboratories played a key role. The research is integral to new physical distancing guidelines.
Kimberley Evason, MD, PhD, and Gregory Ducker, PhD, are two of only 12 scientists nationwide to receive the 2020 Damon-Runyon-Rachleff Innovation Award for their liver cancer research.
In a recently published study, Allie Grossmann, MD, PhD, details one factor behind how and why melanoma metastasizes so quickly while identifying better ways to treat this lethal skin cancer.
Recently, three scientists at ARUP published a study that shows how symptoms of CM-AVM can be distinguished from a similar disorder, hereditary hemorrhagic telangiectasia (HHT).
